Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to -$309.3 million.

  • Healthequity's Enterprise Value rose 400.54% to -$309.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$309.3 million, marking a year-over-year increase of 400.54%. This contributed to the annual value of -$295.9 million for FY2025, which is 2674.17% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Enterprise Value is -$309.3 million, which was up 400.54% from -$304.5 million recorded in Q3 2025.
  • Healthequity's 5-year Enterprise Value high stood at -$161.2 million for Q2 2022, and its period low was -$753.8 million during Q3 2021.
  • For the 5-year period, Healthequity's Enterprise Value averaged around -$342.4 million, with its median value being -$300.2 million (2025).
  • As far as peak fluctuations go, Healthequity's Enterprise Value crashed by 33062.72% in 2021, and later soared by 7811.44% in 2022.
  • Quarter analysis of 5 years shows Healthequity's Enterprise Value stood at -$649.1 million in 2021, then skyrocketed by 67.62% to -$210.2 million in 2022, then plummeted by 58.93% to -$334.1 million in 2023, then rose by 3.56% to -$322.2 million in 2024, then grew by 4.01% to -$309.3 million in 2025.
  • Its Enterprise Value was -$309.3 million in Q4 2025, compared to -$304.5 million in Q3 2025 and -$287.9 million in Q2 2025.